Is Centrifuge a Good Investment?
| TVL | $1.9B |
| FDV | $168M |
| TVL/FDV | 11.31x |
| Risk Grade | B- |
| Value Grade | C+ |
Value Accrual: Does the Centrifuge Token Capture Value?
Centrifuge scores C+ on Hindenrank's value accrual framework (53/100), indicating average value capture — some strengths offset by weaknesses in fee distribution or sustainability. Fee capture scores 11/25 — moderate, with some fees reaching token holders but room for improvement. Token distribution is rated 6/25 (significantly concentrated among insiders or early investors), and emission sustainability sits at 16/25. The competitive moat dimension scores 20/25.
Protocol Health: Is Centrifuge Still Growing?
Centrifuge's vitality risk score is 2/10 on Hindenrank's rubric (lower is healthier). This indicates strong protocol health — active development, growing TVL, and an engaged community. Centrifuge shows signs of a thriving ecosystem that continues to attract users and developers.
Risk-Adjusted View: Is the Upside Worth the Risk?
Risk-Adjusted Position
Safe but StaleCentrifuge falls in the Safe but Stale zone — low risk (B-) but middling value capture (C+). The protocol is well-built and battle-tested, but its token may not capture much upside from growth. This positioning can be appropriate for risk-averse allocators who prioritize capital preservation.
Risk Context
Centrifuge carries a risk grade of B- (35/100), classified as moderate risk — some novel mechanisms, generally well-understood. While no critical-severity interactions were identified, 2 high-severity interactions warrant attention. The primary risk factor is: Real-world asset counterparty and default risk is inherently opaque on-chain; 2023 default event exposed originator vetting weaknesses
Read our full safety analysis →Where Centrifuge Sits Among RWA Peers
On risk, Centrifuge ranks #30 of 73 RWA protocols (above-median). That's 3 points safer than the sector average of 38/100.
The closest peer by risk profile is BackedFi (grade B-, 35/100). See the side-by-side comparison to weigh their tradeoffs.
Centrifuge captures 6% of TVL across rated RWA protocols — a meaningful share that shapes fundamentals.
Should you buy Centrifuge?
Centrifuge scores C+ on Hindenrank's value accrual framework, placing it among the average RWA protocols. Fee capture scores 11/25 — moderate, with some fees reaching token holders but room for improvement. Token distribution is significantly concentrated among insiders or early investors, and emission sustainability sits at 16/25. On the risk side, Centrifuge carries a B- grade (35/100), which is moderate risk — some novel mechanisms, generally well-understood. The combined risk-value position places Centrifuge in the Safe but Stale quadrant.
Centrifuge investment outlook for 2026
With $1.9B in total value locked and FDV of $168M, giving a TVL/FDV ratio of 11.31, Centrifuge's fundamentals do not strongly support the current valuation from a usage perspective. The competitive moat dimension scores 20/25, suggesting durable structural advantages that are difficult for competitors to replicate.Investors should weigh these fundamentals alongside market conditions and their own risk tolerance.
This analysis is based on cryptoeconomic fundamentals, not price prediction. It is not financial advice. Full methodology
Weekly Commentary
ProWeek of April 1, 2026
Centrifuge presents a classic disconnect: solid infrastructure with broken tokenomics. The B- risk grade reflects its actual safety—$1.6B in TVL backed by real-world assets and a 20/25 competitive moat in the RWA space. But the C+ value score (53/100) exposes why capital has stalled. Fee capture sits at just 11/25, meaning token holders see minimal direct upside from the platform's growth. With token distribution scoring only 6/25, governance concentration likely limits retail appeal. The 14.80 TVL/FDV ratio suggests the market has priced in minimal growth, and the 2/10 vitality score confirms it—this is a stale project, not an improving one. The core problem is emission sustainability at 16/25. Centrifuge's issuance structure is eating into token value. Competitive moat is strong (20/25), and the RWA thesis remains intact as traditional finance creeps on-chain, but the protocol hasn't aligned its token design with its narrative. A real RWA play should accumulate value *for token holders* as TVL grows. Centrifuge's architecture doesn't. This isn't a risk story—the protocol is operationally sound. It's a value story: you're holding a ticket to a thriving infrastructure platform that doesn't pay dividends. The vitality collapse is the real red flag. At 2/10, this signals either abandoned development or minimal iteration. For an RWA protocol in a space that demands regulatory sophistication and product polish, stagnation is dangerous. Competitors in the tokenized real-world asset space (MakerDAO's real-world vault strategy, Ondo Finance, others) are moving faster. Watch whether Centrifuge's next rescan shows any developer activity pickup or new mechanism deployment. Without it, "safe but stale" drifts toward obsolescence. The moat holds today; it won't hold if the protocol can't iterate.
Exploring options?
Compare RWA Alternatives →Related RWA Investment Analyses
Related RWA Safety Analyses
Get risk alerts before it's too late
Weekly grade changes, downgrade alerts, and new protocol risk findings. Free.